semaglutide for parkinson's GLP-1 drug may help with disease, study reports Beyond insulin: The Intriguing role

Im still figuring out what the best maintenance dose is for myself but no matter the dose it will be coming from Citizen Meds

Lighter dinner, no alcohol, earlier wind-down

Next, the researchers examined voluntary drinking habits in both male and female rats

Our protocol goes far beyond the script, combining unlimited access to expert providers, personalized nutrition support, app-based tracking, and a connected patient community. In a retrospective analysis of 1,131 patients treated with the GLP-1 drug semaglutide, combined with individualized medical oversight, patients lost an average of 45.9 pounds (19.5% total body weight loss) at 52 weeks, with those extending to 68 weeks achieving an average total weight loss of 46.9 pounds (21.8%)

Both medications are designed to support long-term metabolic improvements and sustainable weight management

increasing the overall insulin production and decreasing how much sugar is even produced by the liver